Aging changes and medical complexity in late-life bipolar disorder: Emerging research findings that may help advance care

Neuropsychiatry

Volumn 3, Issue 6, 2013, Pages 621-633

  Sajatovic, Martha ^a   Forester, Brent P ^b   Gildengers, Ariel ^c   Mulsant, Benoit H ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LAMOTRIGINE; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; QUETIAPINE; THIAZIDE DIURETIC AGENT; VALPROATE SEMISODIUM;

AGING; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; HUMAN; HYPERTENSION; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT CARE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; VERBAL MEMORY; WORKING MEMORY;

EID: 84890399808     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.13.78     Document Type: Review

References (98)

1. CDC. Trends in aging - United States and worldwide. MMWR Morb. Mortal. Wkly Rep. 52(6), 101-104, 106 (2003
2. Jeste DV, Alexopoulos GS, Bartels SJ et al. Consensus statement on the upcoming crisis in geriatric mental health: Research agenda for the next 2 decades. Arch. Gen. Psychiatry 56(9), 848-853 (1999
3. Fountoulakis KN, Vieta E. Treatment of bipolar disorder: A systematic review of available data and clinical perspectives. Int. J. Neuropsychopharmacol. 11(7), 999-1029 (2008
4. Young RC, Gyulai L, Mulsant BH et al. Pharmacotherapy of bipolar disorder in old age: Review and recommendations. Am. J. Geriatr Psychiatry 12(4), 342-357 (2004
5. Depp CA, Jeste DV. Bipolar disorder in older adults: A critical review. Bipolar Disord. 6(5), 343-367 (2004
6. Depp CA, Lindamer LA, Folsom DP et al. Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am. J. Geriatr. Psychiatry 13(4), 290-298 (2005
7. Yassa R, Nair V, Nastase C, Camille Y, Belzile L. Prevalence of bipolar disorder in a psychogeriatric population. J. Affect. Disord. 14(3), 197-201 (1988
8. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: Follow-up over 34-38 years. J. Affect. Disord. 68(2-3), 167-181 (2002
9. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA 298(15), 1794-1796 (2007
10. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58(9), 844-850 (2001
11. Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese Jr. Medical comorbidity in bipolar disorder: Relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord. 12(4), 404-413 (2010
12. Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: A literature review. J. Geriatr. Psychiatry Neurol. 25(1), 20-25 (2012
13. Gildengers AG, Tatsuoka C, Bialko C et al. Correlates of disability in depressed older adults with bipolar disorder. Cutting Edge Psychiatry in Practice 3, 332-338 (2013
14. Miller MD, Paradis CF, Houck PR et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res. 41(3), 237-248 (1992
15. Epping-Jordan J, Üstün B. The WHODAS II: Leveling the playing field for all disorders. WHO Bulletin of Mental Health 6, 5-6 (2000
16. Leboyer M, Kupfer DJ. Bipolar disorder: New perspectives in health care and prevention. J. Clin. Psychiatry 71(12), 1689-1695 (2010
17. Citrome L, Vreeland B. Schizophrenia, obesity, and antipsychotic medications: What can we do? Postgrad. Med. 120(2), 18-33 (2008
18. Fuller MA, Sajatovic M. Drug Information Handbook for Psychiatry Lexi-Comp, OH, USA (2009
19. Mitchell PB. Therapeutic drug monitoring of psychotropic medications. Br. J. Clin. Pharmacol. 52(Suppl. 1), S45-S54 (2001
20. Al Jurdi RK, Marangell LB, Petersen NJ, Martinez M, Gyulai L, Sajatovic M. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a 'recovered' status in the systematic treatment enhancement program for bipolar disorder. Am. J. Geriatr. Psychiatry 16(11), 922-933 (2008
21. Chen P, Korobkova I, Busby K, Sajatovic M. Managing late-life bipolar disorder: An update. Aging Health 7(4), 557-571 (2011
22. Dunner DL. Drug interactions of lithium and other antimanic/mood- stabilizing medications. J. Clin. Psychiatry 64(Suppl. 5), 38-43 (2003
23. Sajatovic M, Dawson NV, Perzynski AT et al. Best practices: Optimizing care for people with serious mental illness and comorbid diabetes. Psychiatr. Serv. 62(9), 1001-1003 (2011
24. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol. Med. 38(6), 771-785 (2008
25. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disord. 3(3), 106-150; discussion 151-103 (2001
26. Bora E, Yucel M, Pantelis C. Cognitive impairment in affective psychoses: A meta-analysis. Schizophr. Bull. 36(1), 112-125 (2010
27. Born C, Seitz NN, Grunze H et al. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology. Acta Psychiatr. Scand. 120(6), 474-480 (2009
28. Bourne C, Aydemir O, Balanza-Martinez V et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis. Acta Psychiatr. Scand. 128(3), 149-162 (2013
29. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J. Affect. Disord. 93(1-3), 105-115 (2006
30. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: A meta-analysis. Acta Psychiatr. Scand. Suppl. (434), 17-26 (2007
31. Bowie CR, Depp C, Mcgrath JA et al. Prediction of real-world functional disability in chronic mental disorders: A comparison of schizophrenia and bipolar disorder. Am. J. Psychiatry 167(9), 1116-1124 (2010
32. Bearden CE, Shih VH, Green MF et al. The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: A prospective study. Bipolar Disord. 13(4), 323-333 (2011
33. Savitz J, Solms M, Ramesar R. Neuropsychological dysfunction in bipolar affective disorder: A critical opinion. Bipolar Disord. 7(3), 216-235 (2005
34. Berk M, Conus P, Kapczinski F et al. From neuroprogression to neuroprotection: Implications for clinical care. Med. J. Aust. 193(4 Suppl.), S36-S40 (2010
35. Leboyer M, Soreca I, Scott J et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J. Affect. Disord. 141(1), 1-10 (2012
36. Andreasen NC. The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin. Neurosci. 12(3), 409-415 (2010
37. Drysdale E, Knight HM, McIntosh AM, Blackwood DH. Cognitive endophenotypes in a family with bipolar disorder with a risk locus on chromosome 4. Bipolar Disord. 15(2), 215-222 (2013
38. Gildengers AG, Chisholm D, Butters MA et al. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: Evidence for neuroprogression? Psychol. Med. 43(4), 1-11 (2012
39. Gildengers AG, Mulsant BH, Al Jurdi RK et al. The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. Bipolar Disord. 12(8), 851-858 (2010
40. Samame C, Martino DJ, Strejilevich SA. A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disord. 15(6), 633-644 (2013
41. Martino DJ, Strejilevich SA, Manes F. Neurocognitive functioning in early-onset and late-onset older patients with euthymic bipolar disorder. Int. J. Geriatr. Psychiatry 28(2), 142-148 (2013
42. Strejilevich SA, Martino DJ. Cognitive function in adulthood and elderly euthymic bipolar patients: A comparison to test models of cognitive evolution. J. Affect. Disord. 150(3), 1188-1191 (2013
43. Greenwood PM. Functional plasticity in cognitive aging: Review and hypothesis. Neuropsychology 21(6), 657-673 (2007
44. Manji HK, Quiroz JA, Sporn J et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 53(8), 707-742 (2003
45. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl Acad. Sci. USA 95(22), 13290-13295 (1998
46. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann. NY Acad. Sci. 836, 253-268 (1997
47. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48(8), 766-777 (2000
48. Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed 8(3), 46 (2006
49. Nebes RD, Pollock BG, Meltzer CC et al. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 65(9), 1487-1489 (2005
50. Nebes RD, Pollock BG, Mulsant BH et al. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol. Bull. 33(4), 715-720 (1997
51. Chew ML, Mulsant BH, Pollock BG et al. Anticholinergic activity of 107 medications commonly used by older adults. J. Am. Geriatr. Soc. 56(7), 1333-1341 (2008
52. Depp CA, Savla GN, Moore DJ et al. Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disord. 10(6), 684-690 (2008
53. Delaloye C, Moy G, De Bilbao F et al. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder. Int. J. Geriatr. Psychiatry 26(12), 1309-1318 (2011
54. Moorhead TW, Mckirdy J, Sussmann JE et al. Progressive gray matter loss in patients with bipolar disorder. Biol. Psychiatry 62(8), 894-900 (2007
55. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Persistent neuropsychological deficit in euthymic bipolar patients: Executive function as a core deficit. J. Clin. Psychiatry 68(7), 1078-1086 (2007
56. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Long-term stability of cognitive impairment in bipolar disorder: A 2-year follow-up study of lithium-treated euthymic bipolar patients. J. Clin. Psychiatry, 69(5), 712-719 (2008
57. Dhingra U, Rabins PV. Mania in the elderly: A 5-7 year follow-up. J. Am. Geriatr. Soc. 39(6), 581-583 (1991
58. Gildengers AG, Mulsant BH, Begley A et al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord. 11(7), 744-752 (2009
59. Engelsmann F, Katz J, Ghadirian AM, Schachter D. Lithium and memory: A long-term follow-up study. J. Clin. Psychopharmacol. 8(3), 207-212 (1988
60. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch. Gen. Psychiatry 65(9), 1017-1032 (2008
61. Thomas AJ, Perry R, Barber R, Kalaria RN, O'Brien JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann. NY Acad. Sci. 977, 333-339 (2002
62. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: A quantitative review. Neuropsychology 14(2), 224-232 (2000
63. Beyer JL, Kuchibhatla M, Payne M et al. Caudate volume measurement in older adults with bipolar disorder. Int. J. Geriatr. Psychiatry 19(2), 109-114 (2004
64. Altshuler LL, Bartzokis G, Grieder T et al. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol. Psychiatry 48(2), 147-162 (2000
65. Doty TJ, Payne ME, Steffens DC, Beyer JL, Krishnan KR, Labar KS. Age-dependent reduction of amygdala volume in bipolar disorder. Psychiatry Res. 163(1), 84-94 (2008
66. Rej S, Butters MA, Aizenstein HJ et al. Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age. Int. J. Geriatr. Psychiatry doi:10.1002/gps.4021 (2013) (Epub ahead of print
67. Delaloye C, De Bilbao F, Moy G et al. Neuroanatomical and neuropsychological features of euthymic patients with bipolar disorder. Am. J. Geriatr. Psychiatry 17(12), 1012-1021 (2009
68. Vederine FE, Wessa M, Leboyer M, Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 35(8), 1820-1826 (2011
69. Versace A, Almeida JR, Hassel S et al. Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch. Gen. Psychiatry 65(9), 1041-1052 (2008
70. Brooks JO 3rd, Hoblyn JC, Woodard SA, Rosen AC, Ketter TA. Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. J. Psychiatr. Res. 43(5), 497-502 (2009
71. Kumar A, Ajilore O, Deseda J, Woodward M, Rhodes E. Molecular Imaging in Late-Life Depression. In: Late-Life Mood Disorders. Lavretsky H, Sajatovic M, Reynolds CF 3rd (Eds). Oxford University Press, NY, USA (2013
72. Haller S, Xekardaki A, Delaloye C et al. Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder. J. Psychiatry Neurosci. 36(6), 391-401 (2011
73. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 356(9237), 1241-1242 (2000
74. Hajek T, Cullis J, Novak T et al. Hippocampal volumes in bipolar disorders: Opposing effects of illness burden and lithium treatment. Bipolar Disord. 14(3), 261-270 (2012
75. Hajek T, Kopecek M, Hoschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: A meta-analysis. J. Psychiatry Neurosci. 37(3), 110143 (2012
76. Macritchie KA, Lloyd AJ, Bastin ME et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br. J. Psychiatry 196(1), 52-58 (2010
77. Germana C, Kempton MJ, Sarnicola A et al. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr. Scand. 122(6), 481-487 (2010
78. Foland LC, Altshuler LL, Sugar CA et al. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport 19(2), 221-224 (2008
79. Frangou S. Neuroimaging Perspectives of Psychotropic Treatment in Bipolar Disorder. American College of Neuropsychopharmacology, FL, USA (2012
80. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs 19(Suppl. 1), 1-93 (2005
81. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: A selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 32(9), 2060-2067 (2012
82. Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog. Neuropsychopharmacol. Biol. Psychiatry 30(6), 969-995 (2006
83. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: Evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10(10), 900-919 (2005
84. Silverstone PH, Mcgrath BM. Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients. Int. Rev. Psychiatry 21(4), 414-423 (2009
85. Forester BP, Zuo CS, Ravichandran C et al. Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression. J. Geriatr. Psychiatry Neurol. 25(1), 43-50 (2012
86. Forester BP. Neuroimaging correlates of mood and cognition in geriatric bipolar disorder. Presented at: Annual Meeting of the American Association for Geriatric Psychiatry. Los Angeles, CA, USA, March 14-17 2013
87. Forester BP, Streeter CC, Berlow YA et al. Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: A lithium-7 magnetic resonance spectroscopy study. Am. J. Geriatr. Psychiatry 17(1), 13-23 (2009
88. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35(3), 804-817 (2011
89. Pfaffenseller B, Fries GR, Wollenhaupt-Aguiar B et al. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev. Neurother. 13(7), 827-842 (2013
90. Andreazza AC, Kapczinski F, Kauer-Sant'anna M et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 34(4), 263-271 (2009
91. Andreazza AC, Kauer-Sant'anna M, Frey BN et al. Oxidative stress markers in bipolar disorder: A meta-analysis. J. Affect. Disord. 111(2-3), 135-144 (2008
92. Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 67(4), 360-368 (2010
93. Gigante AD, Young LT, Yatham LN et al. Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14(8), 1075-1089 (2011
94. Scola G, Kim HK, Young LT, Andreazza AC. A fresh look at complex I in microarray data: Clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol. Psychiatry 73(2), e4-e5 (2013
95. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Yatham LN, Young LT. Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int. J. Neuropsychopharmacol. 14(8), 1069-1074 (2011
96. Kim HK, Andreazza AC. The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder. Expert Rev. Neurother. 12(7), 849-859 (2012
97. Blumberger DM, Daskalakis ZJ, Mulsant BH. Biomarkers in geriatric psychiatry: Searching for the holy grail? Curr. Opin. Psychiatry 21(6), 533-539 (2008
98. Lenze EJ, Mulsant BH. Biomarkers in geriatric psychiatry. Am. J. Geriatr. Psychiatry 15(10), 827-831 (2007